However, in a recent pilot study involving patients with squamous cell carcinoma of the skin, a high percentage of patients had a pathological complete response with minor toxicity after treatment with two doses of neoadjuvant programmed cell death protein 1 inhibitor before surgery.25 Here, PDCD1 is linked to skin squamous cell carcinoma.